tldrdailynews.com logo
Tag

Shingles Vaccine

All articles tagged with #shingles vaccine

Four simple steps to add healthy years
health14 days ago

Four simple steps to add healthy years

A Vox-tied look at longevity highlights a potential dementia-reducing link from the shingles vaccine, but the practical core emphasizes four actions: stay socially connected to cut isolation-related risk, follow a Mediterranean-style diet for cancer/heart/cognitive benefits, engage in regular strength training to preserve muscle, and prioritize sleep—especially deep sleep—with a consistent schedule. The goal is to maximize healthy years (healthspan) rather than chasing an arbitrary longevity number, and it’s never too late to start.

via Yahoo|
#health#healthspan#longevity
Diet, vaccine, and drug linked to lower stroke risk in new studies
health17 days ago

Diet, vaccine, and drug linked to lower stroke risk in new studies

Three new studies suggest potential stroke-prevention strategies: a Mediterranean-style diet may lower risk of ischemic and hemorrhagic stroke in women; the shingles vaccine was associated with fewer major adverse cardiac events in people with ASCVD in an observational study (not yet peer-reviewed, so causality isn’t established); and the oral anticoagulant asundexian may reduce secondary ischemic stroke risk in patients who’ve had a prior stroke or high‑risk TIA by inhibiting factor XIa. Stroke is a leading cause of death, with many events potentially preventable through lifestyle and medical interventions.

via Medical News Today|
#asundexian#health#mediterranean-diet
Shingrix Vaccine Linked to Lower Dementia Risk in Nursing Home Residents
health19 days ago

Shingrix Vaccine Linked to Lower Dementia Risk in Nursing Home Residents

A Brown University-led analysis of more than 500,000 Medicare beneficiaries found that older adults who received the Shingrix shingles vaccine after entering skilled nursing facilities had about 24% fewer dementia diagnoses over four years compared with those unvaccinated, though the study cannot prove causation and residual differences between groups may influence results.

via SciTechDaily|
#dementia#elderly#gerontology
Shingrix May Cut Dementia Risk by 24% in Seniors, Study Finds
health22 days ago

Shingrix May Cut Dementia Risk by 24% in Seniors, Study Finds

A real-world study of 509,926 nursing‑facility residents found that those who received the Shingrix shingles vaccine within 12 months of admission had a 24% lower risk of developing dementia over four years than unvaccinated peers, though the observational design cannot establish causation. Uptake was low (8,843 vaccinated), and researchers note potential neuroinflammatory mechanisms and confounders; the study was funded by GlaxoSmithKline, and Shingrix’s real‑world cognitive benefits add to questions about why vaccines might protect brain health.

via ScienceAlert|
#dementia#elderly#health
Shingrix May Cut Dementia Risk in Older Americans, Large Study Finds
health2 months ago

Shingrix May Cut Dementia Risk in Older Americans, Large Study Finds

A large U.S. Medicare study (1.5 million beneficiaries) found that older adults who received the two-dose recombinant zoster vaccine (Shingrix) had a lower incidence of dementia than unvaccinated peers, with about a 28–33% reduced risk for any dementia, Alzheimer's disease, and vascular dementia over up to three years and continued protection beyond three years; results are observational and can’t prove causality, but align with other real-world evidence and call for trials to confirm.

via MedPage Today|
#alzheimers-disease#dementia#health
FDA Pulls Vaccine Safety Publications Over Data-Driven Discrepancies
health2 months ago

FDA Pulls Vaccine Safety Publications Over Data-Driven Discrepancies

FDA withdrew the publication of safety studies on COVID-19 and shingles vaccines after authors drew broad conclusions not supported by the underlying data, a move the agency says preserves scientific integrity; the piece also notes vaccine-policy shifts tied to RFK Jr.’s stance, while health officials reiterate that vaccines remain safe and effective.

via ABC News - Breaking News, Latest News and Videos|
#covid-19#fda#health
Shingles vaccine linked to fewer heart complications in people with heart disease
health3 months ago

Shingles vaccine linked to fewer heart complications in people with heart disease

A large observational study of more than 246,000 U.S. adults with established atherosclerotic cardiovascular disease found that receiving at least one shingles vaccine dose (Shingrix or Zostavax) was associated with substantially lower risks of major cardiovascular events within a year, including a 46% drop in major adverse cardiovascular events, 27% fewer heart attacks, 27% fewer strokes, 33% fewer heart failures, and a 61% reduction in death from any cause, compared with unvaccinated peers. The researchers caution that causality cannot be proven from observational data and longer follow-up is needed, but the findings add to evidence that the shingles vaccine may offer broader health benefits and support vaccination guidelines for adults 50 and older, especially those with cardiovascular disease.

via Medical News Today|
#cardiovascular-disease#health#heart-attack
Market-Ready Meds Could Slow Dementia, Panel Finds
health4 months ago

Market-Ready Meds Could Slow Dementia, Panel Finds

An international expert panel identifies eight drugs already on the market as candidates for further study to prevent or slow dementia. The shingles vaccine shows the strongest real‑world signal, with Welsh data suggesting about a 20% reduction in dementia risk among recipients; the newer Shingrix vaccine is anticipated to be at least as effective. Other drugs cited include Viagra (sildenafil), riluzole, Gilenya (fingolimod), and vortioxetine, though evidence for these is less clear and confounded by factors such as lifestyle and relationships. The panel emphasizes more rigorous research and potential trials to determine true benefits at the population level.

via MarketWatch|
#alzheimers#dementia#health
Shingles vaccine tied to lower dementia risk, with newer shots showing stronger signals
health4 months ago

Shingles vaccine tied to lower dementia risk, with newer shots showing stronger signals

Natural-experiment studies across Wales, Australia, Canada, and the US consistently link shingles vaccination with reduced dementia risk, and newer data suggest that Shingrix may offer larger protective benefits than the older Zostavax—potentially by lowering brain inflammation from varicella-zoster reactivation—though causality and gender differences require further study.

via Ars Technica|
#aging#dementia#health
Old Drugs, New Hope: 3 Meds May Help Prevent Alzheimer’s
health5 months ago

Old Drugs, New Hope: 3 Meds May Help Prevent Alzheimer’s

A panel of researchers identified three approved medicines with potential to prevent or treat Alzheimer’s disease: the shingles vaccine (Zostavax), sildenafil (Viagra), and riluzole. These drugs target relevant Alzheimer’s mechanisms, have safety profiles suitable for older adults, and show promising results in cell/animal studies, prompting calls for robust clinical trials to determine true benefit and establish whether they can slow or prevent dementia.

via SciTechDaily|
#alzheimers-disease#drug-repurposing#health
Shingles Shot May Slow the Body's Aging Clock, USC Study Finds
health5 months ago

Shingles Shot May Slow the Body's Aging Clock, USC Study Finds

A USC Leonard Davis School of Gerontology study analyzing the Health and Retirement Study (about 3,800 people aged 70+ in 2016) found that those who received the shingles vaccine had slower biological aging on several measures—lower inflammation and slower epigenetic and transcriptomic aging—than unvaccinated peers, suggesting vaccines may influence aging beyond preventing shingles, with effects lasting at least four years after vaccination; the results show an association, not causation.

via SciTechDaily|
#aging#epigenetic-aging#health
Shingles vaccine linked to slower aging markers in seniors
health5 months ago

Shingles vaccine linked to slower aging markers in seniors

A USC-led observational study using data from the Health and Retirement Study found that adults aged 70+ who received the shingles vaccine showed signs of slower biological aging, including reduced inflammation, slower epigenetic aging, and stronger immunity, with the strongest effects within three years post-vaccination; however, the cross-sectional design means causality can’t be established and further research is needed.

via CIDRAP|
#aging#epigenetic-aging#health